Section 7
Chapter 6,882

Use of stable isotopes in the study of pharmacokinetics of drugs by mass fragmentography II: Detailed examination of pharmacokinetics of a single oral dose of phenytoin in humans

Baba, S.; Goromaru, T.; Yamazaki, K.; Kasuya, Y.

Journal of Pharmaceutical Sciences 69(11): 1300-1307


ISSN/ISBN: 0022-3549
PMID: 7452459
DOI: 10.1002/jps.2600691118
Accession: 006881768

Download citation:  

To study the pharmacokinetics of the anticonvulsant phenytoin in detail, a mass fragmentographic method was applied for the precise, sensitive, and specific analysis of phenytoin, 5-(4-hydroxyphenyl)-5-phenylhydantoin, and 5-(4-hydroxyphenyl)-5-phenylhydantoin glucuronide in plasma and urine after administration of a single oral dose of phenytoin to 2 healthy volunteers. Salivary phenytoin concentrations were measured. Phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin were analyzed after the addition of deuterium-labeled internal standards and conversion to volatile methyl derivatives for mass fragmentographic analysis. The lower limit of detection was .apprx. 10 ng/ml. The simultaneous pharmacokinetic analysis of the plasma levels and urinary excretion data of phenytoin and its major metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, yielded detailed information about the pharmacokinetics of phenytoin.

PDF emailed within 0-6 h: $19.90